Flagship Pioneering
Capital Type
Venture Capital
Investment Size
Undisclosed / varies by deal
Geographic Scope
US, Global
Return Model
Dilutive
Stage Focus
Company creation, Seed, Early-stage
Modality Focus
Microbiome, Platforms, Novel modalities
Overview
Platform-focused venture creation firm that builds companies around novel biology, computation, and enabling technologies.
Portfolio and Signals
AMR relevance is strongest for microbiome, platform, and novel modality companies rather than conventional antibiotic developers.
Access and Engagement
Access is highly relationship- and thesis-driven.
Notable AMR Examples / Programs
Company-creation engine with adjacent relevance
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
